Integrated Oncogenomic Profiling of Copy Numbers and Gene Expression in Lung Adenocarcinomas without EGFR Mutations or ALK Fusion

Targeted therapies based on EGFR mutations or on the ALK fusion oncogene have become the standard treatment for certain patients with lung adenocarcinoma (LUAD). However, most LUAD patients have no EGFR mutation or ALK fusion, and their oncogenetic alterations remain to be characterized. Here we con...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Cancer
Egile Nagusiak: Luo, Yanzhuo, Li, Bingjin, Zhang, Guangxin, He, Yuxiao, Bae, Jeeyoo Hope, Hu, Fengping, Cui, Ranji, Liu, Runhua, Wang, Zhou, Wang, Lizhong
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Ivyspring International Publisher 2018
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5868177/
https://ncbi.nlm.nih.gov/pubmed/29581789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.23909
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak